3.5235
-0.1765
(-4.77%)
At close: January 10 at 4:00:00 PM EST
3.2500
-0.27
(-7.76%)
After hours: January 10 at 5:49:02 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
8,230.1320
-9,556.9510
-10,428.1330
-10,675.3900
-7,317.1690
Investing Cash Flow
-23,145.2940
--
6.3750
-157.0200
-244.4380
Financing Cash Flow
15,011.7340
5,966.0660
8,620.9210
17,582.9260
4,997.5030
End Cash Position
5,501.1010
2,458.9510
6,013.8160
7,899.6900
1,230.6770
Capital Expenditure
--
--
--
-63.8650
-20.0770
Issuance of Capital Stock
14,185.5420
6,153.9870
5,377.7190
17,745.2070
5,000.0000
Issuance of Debt
--
--
--
--
278.1900
Repayment of Debt
--
--
--
-212.2820
--
Repurchase of Capital Stock
--
--
-15.6290
--
--
Free Cash Flow
8,178.8450
-9,556.9510
-10,428.1330
-10,739.2550
-7,337.2460
12/31/2020 - 2/13/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
QNRX Quoin Pharmaceuticals, Ltd.
0.6215
-0.26%
ENSC Ensysce Biosciences, Inc.
7.49
-5.31%
PALI Palisade Bio, Inc.
1.9100
-4.98%
PXMD PaxMedica, Inc.
0.0580
-10.77%
REVB Revelation Biosciences, Inc.
0.5288
-8.83%
ALLR Allarity Therapeutics, Inc.
1.0400
-2.80%
DRMA Dermata Therapeutics, Inc.
1.2000
-4.76%
IPSC Century Therapeutics, Inc.
0.9900
-7.48%
CING Cingulate Inc.
4.8100
+11.60%
RLMD Relmada Therapeutics, Inc.
0.4124
-8.76%